DBV Technologies (DBVT) EBIT Margin (2014 - 2026)
DBV Technologies (DBVT) reported EBIT Margin of 5322.22% for Q1 2026, down 199722.0% year-over-year from N/an in Q1 2025, and up 23.8% on a QoQ basis from 6984.65% in Q4 2025.
DBV Technologies (DBVT) has 11 years of EBIT Margin data on file, last reported at 5322.22% in Q1 2026.
- Quarterly EBIT Margin fell 199722.0% year-over-year to 5322.22% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 2910.43% (up 32408.0% YoY) and the FY2025 annual result came in at 2609.23%, up 19947.0% from the prior year.
- EBIT Margin climbed to 5322.22% in Q1 2026 per DBVT's latest filing, from 6984.65% in the prior quarter.
- Across five years, EBIT Margin topped out at 2915.41% in Q4 2022 and bottomed at 6984.65% in Q4 2025.
- The 5-year median for EBIT Margin is 1558.08% (2022), against an average of 2073.67%.
- The widest annual swing landed in 2022, when EBIT Margin surged 337507 bps; it then tumbled 453516 bps in 2024.
- Tracing DBVT's EBIT Margin over 5 years: stood at 2915.41% in 2022, then tumbled by 105 bps to 134.31% in 2023, then sank by 3377 bps to 4669.47% in 2024, then tumbled by 50 bps to 6984.65% in 2025, then increased by 24 bps to 5322.22% in 2026.
- Per Business Quant, the three latest DBVT EBIT Margin figures stand at 5322.22% (Q1 2026), 6984.65% (Q4 2025), and 1235.65% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -6.43% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 38.10% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 17.83% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 23.02% |
| 10 | DBV Technologies | 8.00 Bn | 7.77 Bn | -3.90 Mn | -5,322.22% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5,322.22% |
| Dec 31, 2025 | -6,984.65% |
| Sep 30, 2025 | -1,235.65% |
| Jun 30, 2025 | -2,806.21% |
| Mar 31, 2025 | -3,325.00% |
| Dec 31, 2024 | -4,669.47% |
| Sep 30, 2024 | -2,829.10% |
| Jun 30, 2024 | -2,914.90% |
| Mar 31, 2024 | -2,029.71% |
| Dec 31, 2023 | -134.31% |
| Sep 30, 2023 | -770.24% |
| Jun 30, 2023 | -1,095.98% |
| Mar 31, 2023 | -964.68% |
| Dec 31, 2022 | 2,915.41% |
| Sep 30, 2022 | -868.85% |
| Jun 30, 2022 | -1,558.08% |
| Mar 31, 2022 | -658.72% |
| Dec 31, 2021 | -459.65% |
| Sep 30, 2021 | -1,841.87% |
| Jun 30, 2021 | -2,092.34% |
| Mar 31, 2021 | -1,007.62% |
| Dec 31, 2020 | 3,313.61% |
| Sep 30, 2020 | -715.85% |
| Jun 30, 2020 | -1,321.16% |
| Mar 31, 2020 | -873.35% |
| Sep 30, 2019 | -1,189.68% |
| Dec 31, 2018 | 474.73% |
| Sep 30, 2018 | -1,476.96% |
| Dec 31, 2015 | -470.57% |
| Jun 30, 2015 | -13,812.04% |
| Dec 31, 2014 | -454.14% |
| Jun 30, 2014 | -11,706.51% |